• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth.

作者信息

Bernardus R E, Jones G S, Acosta A A, Garcia J E, Liu H C, Jones D L, Rosenwaks Z

出版信息

Fertil Steril. 1985 Mar;43(3):373-8. doi: 10.1016/s0015-0282(16)48434-7.

DOI:10.1016/s0015-0282(16)48434-7
PMID:3920087
Abstract

Among the patients enrolled in the Norfolk In Vitro Fertilization Program there were 32 who had been stimulated according to the basic stimulation protocol using two ampules of human menopausal gonadotropin (hMG) daily. Because of their inadequate response, 23 of these 32 patients were stimulated subsequently with a combination of two ampules of "pure" follicle-stimulating hormone (FSH) and two ampules of hMG on cycle days 3 and 4. The remaining nine patients received four ampules of "pure" FSH only on cycle days 3 and 4. Stimulation was continued with hMG in both FSH regimens. Ten thousand units of human chorionic gonadotropin was used for final maturation. Parallel with the increase in the ratio of exogenous FSH to luteinizing hormone, an increase in oocyte recovery was observed, as well as an improvement in transfer and pregnancy rates. It was concluded that FSH enrichment had a beneficial effect in these patients.

摘要

相似文献

1
The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth.
Fertil Steril. 1985 Mar;43(3):373-8. doi: 10.1016/s0015-0282(16)48434-7.
2
Comparison of different follicle-stimulating hormone and luteinizing hormone ratios for ovulation induction during in vitro fertilization.体外受精过程中不同促卵泡激素与促黄体生成素比例用于诱导排卵的比较。
Int J Fertil. 1992 Nov-Dec;37(6):335-8.
3
Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.克罗米芬抵抗性无排卵女性的促排卵治疗:纯化尿促卵泡素(FSH)与纯化尿FSH和促黄体生成素的卵泡反应差异
J Clin Endocrinol Metab. 1985 May;60(5):922-7. doi: 10.1210/jcem-60-5-922.
4
The effect of follicle-stimulating hormone without additional luteinizing hormone on follicular stimulation and oocyte development in normal ovulatory women.在正常排卵女性中,无额外黄体生成素的促卵泡激素对卵泡刺激和卵母细胞发育的影响。
Fertil Steril. 1985 May;43(5):696-702. doi: 10.1016/s0015-0282(16)48550-x.
5
The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization.
Fertil Steril. 1985 Jul;44(1):62-9. doi: 10.1016/s0015-0282(16)48678-4.
6
Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.在低促性腺激素性性腺功能减退女性中,尽管使用恒定低剂量的促黄体生成素,仍可诱导卵泡生长并产生正常的激素环境。
Hum Reprod. 1994 Mar;9(3):431-6. doi: 10.1093/oxfordjournals.humrep.a138523.
7
Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.在体外受精中使用去除促黄体生成素的促卵泡生成素制剂以实现卵泡生长的意义。
Gynecol Endocrinol. 1998 Feb;12(1):9-15. doi: 10.3109/09513599809024964.
8
A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.比较使用重组促黄体生成激素(LH)或作为 LH 类似物的人绒毛膜促性腺激素刺激的体外受精周期在卵巢储备良好或较差的受试者中的结局:回顾性分析。
Eur J Obstet Gynecol Reprod Biol. 2014 Jan;172:70-3. doi: 10.1016/j.ejogrb.2013.10.027. Epub 2013 Nov 5.
9
Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle-stimulating hormone.在接受促性腺激素释放激素激动剂和促卵泡激素治疗的女性体外受精周期的卵泡晚期,促黄体生成素可增加雌二醇分泌,但对孕酮浓度无影响。
Fertil Steril. 1998 Mar;69(3):450-3. doi: 10.1016/s0015-0282(97)00559-1.
10
Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination.
Hum Reprod. 1997 Sep;12(9):1886-9. doi: 10.1093/humrep/12.9.1886.

引用本文的文献

1
Low- versus high-dose human menopausal gonadotropin in an in vitro fertilization-embryo transfer program.
J Assist Reprod Genet. 1995 Apr;12(4):235-8. doi: 10.1007/BF02212924.
2
Ultrasonic and endocrinologic relationships in spontaneous and induced follicular phase.自发和诱导卵泡期的超声与内分泌关系
J Endocrinol Invest. 1988 Jan;11(1):7-13. doi: 10.1007/BF03350085.
3
Preovulatory serum gonadotropin levels in hMG stimulated menstrual cycles in pregnant and nonpregnant patients.
Arch Gynecol. 1987;240(1):49-56. doi: 10.1007/BF02134064.
4
Drugs used in in vitro fertilisation procedures.体外受精程序中使用的药物。
Drugs. 1989 Jul;38(1):148-59. doi: 10.2165/00003495-198938010-00006.
5
Preliminary data on the efficacy of a new human menopausal gonadotropin (hMG) preparation containing a reduced amount of luteinizing hormone (LH) for superovulation in an in vitro fertilization (IVF) program.一种新型人绝经期促性腺激素(hMG)制剂的初步数据,该制剂中促黄体生成素(LH)含量降低,用于体外受精(IVF)程序中的超排卵。
J Assist Reprod Genet. 1992 Aug;9(4):404-6. doi: 10.1007/BF01203968.